Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
ProBiotix Health PLC - Developing probiotics to tackle cardiovascular disease and other lifestyle conditions - Announces new commercialisation partner, Nutraconnect, in the Asia Pacific region. Nutraconnect is a nutraceutical business growth acceleration service based in Singapore. Nutraconnect will help develop go-to-market strategies for ProBiotix's products. Nutraconnect has ‘established network of industry contacts and a wealth of experience in successfully bringing innovative and science back ingredients and products to markets in the region’, ProBiotix says.
Current stock price: 21.5 pence
12-month change: up 2.4%, from 21 pence IPO price in March
Copyright 2022 Alliance News Limited. All Rights Reserved.